Professional Documents
Culture Documents
49. A counselling point when dispensing colesevelam to 55. Adverse effect associated with estrogen therapy
a patient on a warfarin therapy.
A. Breast tenderness
A. Stop taking warfarin for his B. Nausea
interacts with colesevelam C. Thromboembolism
B. Take warfarin 1 to 2 hours before D. Breast cancer
or 4 to 6 hours after the bile acid- E. All of these
binding resin
56. Which of the following antidiabetic drugs is
C. Switch colesevelam to
associated with a risk of pancreatitis?
cholestyramine
D. Take both drugs at the same time A. Metformin
with food B. Liraglutide
E. Take both drugs at the same time C. Glimepiride
on an empty stomach D. Insulin
E. Nateglinide
50. Which of the following patient groups would be more
likely to experience the adverse effect of HMG coa 57. A patient on warfarin therapy brought in a
reductase inhibitors (myopathy and rhabdomyolysis)? prescription for naproxen. Upon consult, you were
informed that he did not tell his prescriber that he is
A. Patients with on blood thinners
taking warfarin. You recall that warfarin is 97% protein
B. Patients with heperuriemia
C. Patients with hypertension
bound and naproxen is 99% protein bound. What would C. Biopharmaceutical
happen if this patient takes naproxen? D. Pharmacodynamic
E. Pharmaceutical
A. The patient will benefit from this
combination 63. A contraindication for the use of ergotamine and
B. The pain and inflammation will be dihydroergotamine
treated
C. There is no interaction between I. Angina
the two drugs II. Peripheral vascular disease
D. The patient may experience III. Diabetes
bleeding A. I only
E. The patient would have blood B. III only
clots C. I and II only
D. II and III
58. This should be checked by the pharmacist when E. I, II and III
dispensing suppositories
64. An antimicrobial agent that have the potential to
A. Excessive softening cause interstitial nephritis
B. Oil stains on packaging
C. Presence of precipitate A. Methicillin
D. A and B B. Ceftriaxone
E. B and C C. Naproxen
D. Cephalexin
59. The following are common side effects encountered E. Sertraline
when using ophthalmic preparations EXCEPT
65. Red man syndrome is an adverse event associated
A. Persistent burning sensation with which medication
B. Tearing
C. Decreased vision A. Erythromycin
D. Foreign body sensation B. Vancomycin
E. Margin crusting C. Ciprofloxacin
D. Moxifloxacin
60. A patient brought in a prescription for finasteride. E. Daptomycin
Your pharmacy technician assigned at the filling station
is in her 1st trimester of pregnancy. What precautions 66. An adverse effect associated with the use of
should be observed? daptomycin
A. Garlic A. Complexation
B. Ginger B. Reduction
C. Feverfew C. Photolysis
D. A and B D. Oxidation
E. A,B, and C E. All of these
81. Interaction between St. John’s wort and calcium 86. Factors affecting IV compatibility
channel blockers result to:
A. Ph
A. Failure of therapy of calcium B. Order of mixing
channel blockers C. Length of time in solution
B. Failure of therapy of St. John’s D. Temperature
wort E. All of these
C. There is no interaction between
St. John’s wort and calcium channel 87. Therapeutic hazards for IV preparations
blockers A. Drug instability
D. Elevated levels of St. John’s wort B. Labelling errors
E. Elevated levels of calcium C. Preservative and solubilizing agent toxicity
channel blockers D. Incompatibility
82. A patient asks you for a recommendation for an over E. All of these
the counter product for hot flashes due to menopause. 88. The interaction between ginkgo biloba and warfarin
Black cohosh is a common herbal supplement indicated could result to
for hot flashes. However further interview revealed that
she has maintenance medications for hypertension. I. Increased risk of bleeding
What would happen if she takes black cohosh together II. Decreased risk of bleeding
with her antihypertensive? III.Antagonism
A. I only
A. Hypertension B. III only
B. No interaction C. I and II only
C. Treatment failure of black cohosh D. II and III
D. Hypotension E. I, II and III
E. None of these
89. The mechanism for the interaction between ethanol
83. Factors that increase the chances of a drug and phenobarbital
interaction to occur
A. Increased metabolism of phenobarbital
I. Multiple prescribers B. Decreased metabolism of phenobarbital
II. Multiple drug therapy C. Decreased absorption of phenobarbital
III. Geriatric therapy D. Decreased metabolism of ethanol
A. I only E. None of these
B. III only
C. I and II only 90. False-positive urine ketone tests may result in
D. II and III patients taking valproic acid. This is significant for this
E. I, II and III type of patients when using urine tests
127. The following are adverse effects commonly A. Increased clearance of theophylline
observed in patients treated with propranolol, EXCEPT B. Decreased clearance of theophylline
C. Decreased clearance of cimetidine
A. Bronchodilation D. Increased clearance of cimetidine
B. Sexual impairment E. No change in clearance profiles of both drugs
C. Arrythmia (with abrupt withdrawal)
D. Fatigue 133. Sudden cessation of beta blockers could result in
E. Bronchoconstriction A. Cardiac arrythmia
128. These substances may liquefy or form eutectic B. Hypotension
mixtures when in close, prolonged contact with one C. Angina
another D. Bronchodilation
E. None of these
A. Aspirin
B. Phenol 134. Common side effect of colchicine
C. Camphor A. Nausea
D. Menthol B. Alopecia
E. All of these C. Aplastic anemia
129. All of the following are drugs with narrow D. Diarrhea
therapeutic indices, EXCEPT E. All of these
199. The following are adverse effects of nicotine 205. Counselling points for patients on oral
lozenges, EXCEPT bisphosphonates such as alendronate (Fosamax)
A. Skin irritation on application site I. Take this on an empty stomach first thing
B. Nausea in the morning
C. Insomnia II. Take with a full glass of water
D. Dyspepsia III.Remain in an upright position for at least
E. Coughing 30 minutes after taking the drug
A. I only
200. Which of the following is used as an over the B. III only
counter sleep aid? C. I and II only
A. Melatonin D. II and III
B. Valerian root E. I, II and III
C. Doxylamine 206. Food – alendronate interaction results in
D. Diphenhydramine
E. All of these A. Decreased absorption of alendronate
B. Increased absorption of alendronate
201. An over the counter cough preparation that is C. Decreased elimination of alendronate
recommended for non-productive cough D. Increased metabolism of alendronate
E. None of these C. Direct GI feeding
D. Parenteral admixtures
207. A prostaglandin analog used in the treatment of E. None of these
open angle glaucoma that increases eyelash
prominence, length and darkness. 213. Visible color change or darkening of color is a type
of
A. Latanoprost
B. Bimatoprost I. Physical incompatibility
C. Travoprost II. Chemical incompatibility
D. Tafluprost III. Therapeutic incompatibility
E. Epoprostenol A. I only
B. III only
208. Sildenafil is contraindicated in patients maintained C. I and II only
on nitrates because of D. II and III
A. Severe hypotension E. I, II and III
B. Sexual dysfunction 214. The manifestation of the incompatibility when
C. Priapism phosphate and calcium are combined in solution
D. Severe hypertension
E. Therapeutic failure of nitroglycerin A. Evolution of gas
B. Dark discoloration of solution
209. Which of the following drugs is matched correctly C. Precipitate formation
with its therapeutic use? D. Visible color change
A. Oxybutynin – overactive bladder E. Formation of separate layers
B. Tamsulosin – BPH 215. When penicillin G is given after tetracycline when
C. Tadalafil – erectile dysfunction treating a patient with infection, a reduction in the
D. Androgel – testosterone replacement bactericidal activity of the former is observed
therapy
E. All of these I. Physical incompatibility
II. Chemical incompatibility
210. A precaution when using D5W in parenteral III. Therapeutic incompatibility
preparations A. I only
I. Instability when used with acid-sensitive B. III only
drugs C. I and II only
II. Must be used cautiously in diabetic D. II and III
patients E. I, II and III
III.Instability when used with acidic drugs 216. The following drug classes may cause tinnitus,
A. I only EXCEPT
B. III only
C. I and II only A. Salicylates
D. II and III B. Aminoglycosides
E. I, II and III C. Loop diuretics
D. Penicillins
211. The most serious problem that may occur during E. Chemotherapeutic agents
infusion of antineoplastics
217. A patient was given cefdinir but continued to take
I. too long infusion time iron supplements. What could be the result of this drug
II. Inflammation of a vein interaction?
III.Extravasations
A. I only A. Failure of antibiotic therapy
B. III only B. Patients develop iron- deficiency
C. I and II only anemia
D. II and III C. Cefdinir toxicity
E. I, II and III D. Decreased effect of iron
E. None of these
212. These are large volume admixtures that are used
when enteral nutrition cannot be tolerated. 218. The interaction between theophylline and
erythromycin could result in
A. NGT feeding
B. Total parenteral nutrition
A. Inhibition of metabolism of D. Failure of antibiotic therapy
theophylline E. None of these
B. Toxic accumulation of
theophylline 225. Norfloxacin when taken together with antacids
C. Induction of metabolism of results in
theophylline A. Increased antibiotic effect
D. A and B B. Decreased antibiotic effect
E. B and C C. There is no interaction between
219. Patients treated for 1 week or longer with the two
erythromycin estolate may develop D. Increased CNS effect
E. None of these
A. Cholestatic hepatitis
B. Hypertension 226. The antibiotic associated with gray-baby syndrome
C. Ototoxicity in neonates
D. Renal failure A. Ciprofloxacin
E. None of these B. Sulfamethoxazole
220. Clarithromycin co-administered with cisapride could C. Clindamycin
result in D. Chloramphenicol
E. Trimethoprim
A. Serious cardiac arrythmias
B. Difficulty breathing 227. Fluconazole is prescribed to a patient taking
C. Enzyme depletion sulfonylureas, this could lead to
D. Bradycardia A. Decreased antibiotic effect
E. None of these B. Increased antibiotic effect
221. Clarithromycin and oral anticoagulants when given C. Decreased hypoglycemic effect
together D. Increased hypoglycemic effect
E. None of these
A. Potentiate anticoagulant effect
B. Prothrombin time needs to be 228. Co-administration of ketoconazole with terfenadine
monitored will cause
C. Diminish anticoagulant effect I. Increased terfenadine levels
D. A and B II. Life-threatening dysrrythmias and death
E. B and C III.Increased ketoconazole levesl
222. Tetracycline when given together with phenytoin A. I only
would result to B. III only
C. I and II only
A. Decreased antibiotic effect D. II and III
B. Increased antibiotic effect E. I, II and III
C. Increased phenytoin effect
D. Decreases phenytoin effect 229. Chloroquine and hydrochloroquine are known to
E. None of these concentrate in the liver. These should be used with
caution in this patient group
223. An antibiotic drug class that may cause QT
prolongation A. Those with hepatic disease
B. Those with pulmonary disease
A. Fluoroquinolones C. Those with cardiac disease
B. Tetracyclines D. Those with renal disease
C. Penicillins E. Those with diabetes
D. Macrolides
E. None of these 230. Quinine is contraindicated in patients with
246. Itraconazole has a negative inotropic effect and 253. The major plasma protein involved in drug protein
should be avoided by which patients binding
247. Common adverse effects of zidovudine (AZT) 254. The process by which drugs are eliminated through
the kidneys into the urine
A. Anemia
B. Neutropenia I. Glomerular filtration
C. Headaches II. Tubular reabsorption
D. All of these III.Active tubular secretion
E. None of these A. I only
B. III only
248. A major adverse effect of didanosine (ddl) C. I and II only
A. Pancreatitis D. II and III
B. Renal failure E. I, II and III
C. Headache 255. The effect of the administration of sodium
D. Hepatitis bicarbonate to weakly acidic drugs such as salicylates
E. Diarrhea
A. No effect
249. These agents work by dissolving or breaking down B. Decreased excretion
the outermost layer of skin, causing peeling of the C. Increased excretion
stratum corneum D. All of these
A. Cytostatic agents E. None of these
B. Keratolytic agents 256. Most biologic products are sensitive to which of the
C. Tocolytic agents following
D. Astringents
E. Antimetabolites A. Extreme heat
B. Light
250. An example of a keratolytic agent C. Freezing
A. Coal tar D. Shaking
B. Salicylic acid E. All of these
C. Hydrocortisone OTC 257. Adalimumab (Humira), a monoclonal antibody used
D. Selenium sulphide for treating autoimmune disorders, has a black box
E. Burow’s solution warning of
260. Strategy to manage drug metabolism 267. An auxillary label that is also a warning label about
potential adverse drug reactions, EXCEPT
A. Use of different dosage forms
B. Modification of key functional groups A. Avoid sun exposure
C. Concurrent use of enzyme inhibitors B. May cause drowsiness. Do not drink, drive or
D. All of these operate machinery
E. None of these C. External use only
D. May cause discoloration of urine or feces
261. A patient who is a slow acetylator of isoniazid will E. All of these
experience ________
268. An auxillary label that ensures appropriate dosing
A. Hypertension considerations
B. Peripheral neuropathy
C. Hypotension A. Take with food
D. Hypertrophy B. Take with a full glass of water
E. Arthritis C. Finish all this medication
D. Take on an empty stomach
262. These are morphine-related toxicities E. All of these
A. Diarrhea 269. A patient comes to the pharmacy telling you that
B. Constipation her salbutamol inhaler is not working properly. You recall
C. Respiratory depression that this is a new medication for the patient and this
D. A and B patient denied to be counselled regarding the use of this
E. B and C new medication. What is the best thing to do?
263. A therapeutic advantage of using prodrugs I. Ask the patient to demonstrate how the inhaler
A. Increases water solubility is used
B. Increased oral absorption II. Tell the patient that the device may be
C. Increased duration of action defective
D. Decreased GI irritation III.Remind the patient that she refused
E. All of these counselling regarding this medication
A. I only
264. The process by which a drug reversibly leaves the B. III only
bloodstream and enters the extracellular fluid and the C. I and II only
tissues is known as D. II and III
E. I, II and III
A. Absorption
B. Distribution
270. Patients on which of the following medications B. Mirtazapine (Remeron)
should be strongly reminded that they should always C. Paroxetine (Paxil)
have these with them for emergency use D. Duloxetine (Cymbalta)
E. Fluoxetine (Prozac)
A. Nitroglycerin sublingual tablets
B. Salbutamol inhaler 277. When counselling patients with depression who are
C. Injectable epinephrine on antidepressant medications, they should be informed
D. All of these of which of the following
E. None of these
I. Adherence to the treatment plan is essential to
271. Information that is included during patient achieve a successful outcome
counselling II. The adverse effects of the drugs may occur
immediately, while the resolution of symptoms
A. Route of administration may take 2 to 4 weeks or longer
B. Missed dose instruction III.The resolution of symptoms is immediate
C. Directions for use while the adverse effects may take a while to
D. Frequency of taking the drug occur
E. All of these A. I only
272. These powders contain water of hydration that may B. III only
be released when the powders are triturated or when C. I and II only
stored in an environment of low relative humidity D. II and III
resulting to powders that are damp or pasty. E. I, II and III
294. The interaction between epinephrine and lidocaine, 298. A common side effect of nitrates
a local anesthetic is
A. Hypertension
I. A desired drug interaction B. Headaches
II. Allows local anesthesia with minimal bleeding C. Dry cough
and without systemic absorption while repairing D. Bronchospasm
a skin wound E. Vasoconstriction
III.Epinephrine and lidocaine should not be
administered together 299. A manifestation of aa chemical incompatibility,
A. I only EXCEPT
B. III only A. Evolution of gas
C. I and II only B. Gel formation
D. II and III C. Immiscibility
E. I, II and III D. Photolysis
295. A patient on salbutamol (Ventolin) and salmeterol E. None of these
and fluticasone (Advair) should be informed of the 300. Oral antidiabetic drugs that are structurally different
following with sulfonylureas however exert the blood glucose
I. Salbutamol inhaler should be used during lowering action by the same mechanism
acute asthma attacks A. Metformin
II. Salmeterol and fluticasone is the maintenance B. Insulin
inhaler to be used daily to minimize asthma C. Meglitinides
attacks D. Tolazamide
III.If there is a need to administer both at the E. None of these
same time, administer salbutamol first
A. I only
B. III only
C. I and II only
D. II and III
E. I, II and III